ATE404519T1 - Hyperforinderivate, ihre verwendung sowie diese enthaltende zubereitungen - Google Patents
Hyperforinderivate, ihre verwendung sowie diese enthaltende zubereitungenInfo
- Publication number
- ATE404519T1 ATE404519T1 AT03718778T AT03718778T ATE404519T1 AT E404519 T1 ATE404519 T1 AT E404519T1 AT 03718778 T AT03718778 T AT 03718778T AT 03718778 T AT03718778 T AT 03718778T AT E404519 T1 ATE404519 T1 AT E404519T1
- Authority
- AT
- Austria
- Prior art keywords
- hyperforine
- derivatives
- preparations containing
- adhyperforin
- hyperforin
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
- C07C49/587—Unsaturated compounds containing a keto groups being part of a ring
- C07C49/703—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups
- C07C49/723—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups polycyclic
- C07C49/727—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups polycyclic a keto group being part of a condensed ring system
- C07C49/733—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups polycyclic a keto group being part of a condensed ring system having two rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/013—Esters of alcohols having the esterified hydroxy group bound to a carbon atom of a ring other than a six-membered aromatic ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
- C07C45/62—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by hydrogenation of carbon-to-carbon double or triple bonds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
- C07C45/64—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by introduction of functional groups containing oxygen only in singly bound form
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/78—Separation; Purification; Stabilisation; Use of additives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
- C07C49/587—Unsaturated compounds containing a keto groups being part of a ring
- C07C49/703—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups
- C07C49/713—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups a keto group being part of a six-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
- C07C49/587—Unsaturated compounds containing a keto groups being part of a ring
- C07C49/703—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups
- C07C49/743—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups having unsaturation outside the rings, e.g. humulones, lupulones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/36—Systems containing two condensed rings the rings having more than two atoms in common
- C07C2602/46—Systems containing two condensed rings the rings having more than two atoms in common the bicyclo ring system containing nine carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Neurosurgery (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Psychiatry (AREA)
- Alternative & Traditional Medicine (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Hospice & Palliative Care (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Plant Substances (AREA)
- Semiconductor Lasers (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT2002MI000872A ITMI20020872A1 (it) | 2002-04-23 | 2002-04-23 | Derivati dell'iperforina loro uso e formulazioni che li contengono |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE404519T1 true ATE404519T1 (de) | 2008-08-15 |
Family
ID=11449767
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT03718778T ATE404519T1 (de) | 2002-04-23 | 2003-04-18 | Hyperforinderivate, ihre verwendung sowie diese enthaltende zubereitungen |
Country Status (19)
| Country | Link |
|---|---|
| US (2) | USRE43280E1 (de) |
| EP (1) | EP1497250B1 (de) |
| JP (1) | JP4315818B2 (de) |
| KR (1) | KR100944052B1 (de) |
| CN (1) | CN1290816C (de) |
| AT (1) | ATE404519T1 (de) |
| CA (1) | CA2483205C (de) |
| DE (1) | DE60322871D1 (de) |
| DK (1) | DK1497250T3 (de) |
| ES (1) | ES2311697T3 (de) |
| HK (1) | HK1075654A1 (de) |
| IL (1) | IL164763A (de) |
| IT (1) | ITMI20020872A1 (de) |
| NO (1) | NO329176B1 (de) |
| PL (1) | PL205829B1 (de) |
| PT (1) | PT1497250E (de) |
| RU (1) | RU2320636C2 (de) |
| SI (1) | SI1497250T1 (de) |
| WO (1) | WO2003091194A1 (de) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102772461B (zh) * | 2011-05-11 | 2014-05-14 | 成都康弘药业集团股份有限公司 | 药物组合物在制备预防或治疗老年性痴呆的药物中的应用 |
| BR112013030986A2 (pt) * | 2011-06-03 | 2016-12-06 | Harvard College | análogos de hiperforina, métodos de síntese e usos dos mesmos |
| ITMI20131012A1 (it) * | 2013-06-19 | 2014-12-20 | Indena Spa | Derivati dell'iperforina e loro uso nella malattia di alzheimer |
| US20180071269A1 (en) | 2015-08-12 | 2018-03-15 | Tianxin Wang | Therapeutical methods, formulations and nutraceutical formulations |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU743956B2 (en) | 1998-02-13 | 2002-02-07 | Dr. Willmar Schwabe Gmbh & Co | Stable hyperforin salts, method for producing same and their use in the treatment of Alzheimer's disease |
| CA2320154A1 (en) | 1998-02-13 | 1999-08-19 | Dr. Willmar Schwabe Gmbh & Co. | Use of hyperforin and hyperforin-containing extracts for the treatment and prophylaxis of dementia diseases |
| IT1301679B1 (it) | 1998-06-10 | 2000-07-07 | Indena Spa | Derivati dell'iperforina, loro uso e formulazioni che licontengono. |
-
2002
- 2002-04-23 IT IT2002MI000872A patent/ITMI20020872A1/it unknown
-
2003
- 2003-04-18 ES ES03718778T patent/ES2311697T3/es not_active Expired - Lifetime
- 2003-04-18 PT PT03718778T patent/PT1497250E/pt unknown
- 2003-04-18 PL PL371347A patent/PL205829B1/pl unknown
- 2003-04-18 JP JP2003587762A patent/JP4315818B2/ja not_active Expired - Fee Related
- 2003-04-18 WO PCT/EP2003/004100 patent/WO2003091194A1/en active IP Right Grant
- 2003-04-18 DE DE60322871T patent/DE60322871D1/de not_active Expired - Lifetime
- 2003-04-18 CN CNB038089319A patent/CN1290816C/zh not_active Expired - Fee Related
- 2003-04-18 KR KR1020047016491A patent/KR100944052B1/ko not_active IP Right Cessation
- 2003-04-18 CA CA2483205A patent/CA2483205C/en not_active Expired - Fee Related
- 2003-04-18 AT AT03718778T patent/ATE404519T1/de active
- 2003-04-18 DK DK03718778T patent/DK1497250T3/da active
- 2003-04-18 SI SI200331386T patent/SI1497250T1/sl unknown
- 2003-04-18 RU RU2004131210/04A patent/RU2320636C2/ru not_active IP Right Cessation
- 2003-04-18 US US12/896,158 patent/USRE43280E1/en not_active Expired - Fee Related
- 2003-04-18 US US10/512,067 patent/US7105705B2/en not_active Ceased
- 2003-04-18 EP EP03718778A patent/EP1497250B1/de not_active Expired - Lifetime
-
2004
- 2004-10-21 IL IL164763A patent/IL164763A/en not_active IP Right Cessation
- 2004-10-21 NO NO20044519A patent/NO329176B1/no not_active IP Right Cessation
-
2005
- 2005-09-05 HK HK05107783A patent/HK1075654A1/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| ES2311697T3 (es) | 2009-02-16 |
| EP1497250B1 (de) | 2008-08-13 |
| HK1075654A1 (en) | 2005-12-23 |
| IL164763A0 (en) | 2005-12-18 |
| KR20040111519A (ko) | 2004-12-31 |
| USRE43280E1 (en) | 2012-03-27 |
| JP2005523917A (ja) | 2005-08-11 |
| JP4315818B2 (ja) | 2009-08-19 |
| CA2483205C (en) | 2011-07-05 |
| CN1290816C (zh) | 2006-12-20 |
| AU2003222828A1 (en) | 2003-11-10 |
| NO329176B1 (no) | 2010-09-06 |
| DK1497250T3 (da) | 2008-12-01 |
| KR100944052B1 (ko) | 2010-02-24 |
| EP1497250A1 (de) | 2005-01-19 |
| DE60322871D1 (de) | 2008-09-25 |
| CA2483205A1 (en) | 2003-11-06 |
| CN1646462A (zh) | 2005-07-27 |
| RU2320636C2 (ru) | 2008-03-27 |
| US20050165117A1 (en) | 2005-07-28 |
| WO2003091194A1 (en) | 2003-11-06 |
| RU2004131210A (ru) | 2005-04-10 |
| NO20044519L (no) | 2004-11-02 |
| IL164763A (en) | 2010-02-17 |
| ITMI20020872A0 (it) | 2002-04-23 |
| US7105705B2 (en) | 2006-09-12 |
| PT1497250E (pt) | 2008-11-12 |
| SI1497250T1 (sl) | 2008-12-31 |
| PL205829B1 (pl) | 2010-05-31 |
| PL371347A1 (en) | 2005-06-13 |
| ITMI20020872A1 (it) | 2003-10-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2002233288A1 (en) | Combined use of Enzyme Inhibitors and Pharmaceutical Preparations thereof for the Treatment and Prophylaxis of Arteriosclerosis, for the Treatment and Prevention of Allergic Reactions of Type I According to the Gell and Coombs Classification, and for the Treatment and Prevention of Dermatological Diseases Associated with FO | |
| SI1594833T1 (sl) | Derivati 1-fenilalkankarboksilne kisline za zdravljenje nevrodegenerativnih bolezni | |
| NO20053077L (no) | Terapeutiske formuleringer for behandling av beta-amyloid-relaterte sykdommer. | |
| IL154888A (en) | Aqueous Pharmaceutical Gel Preparation Containing At least One Vitamin D or One Vitamin D Analog At least One Corticosteroid | |
| WO2004006858A3 (en) | Compounds, compositions, and methods employing same | |
| ATE396198T1 (de) | 17alpha-alkyl-17beta-oxy-estratriene und zwischenprodukte zu deren herstellung, verwendung der 17alpha-alkyl-17beta-oxy-estratriene zur herstellung von arzneimitteln sowie pharmazeutische präparate | |
| DE60115029D1 (de) | Pharmazeutische zusammensetzungen enthaltend cannabidiol-derivate | |
| MX9605940A (es) | Compuestos bioaromaticos que llevan un grupo adamantilo en orto, composiciones farmaceuticas y cosmeticas que los contienen y utilizaciones. | |
| IL167250A (en) | Chirale oxazole-arylpropionic acid derivatives, compositions comprising thereof and their use in the preparation of medicaments for the treatment of ppar alpha/ ppar gamma agonists-modulated diseases | |
| MX9708800A (es) | Compuestos biciclicos aromaticos. | |
| WO2005027977A3 (en) | Diclofenac compositions for the treatment of skin disorders | |
| DE602004014163D1 (de) | Pyrimidylpyrrolderivate, die als kinaseinhibitoren wirken | |
| ZA200501714B (en) | Analogues of vitamin d | |
| HK1068606A1 (en) | Novel aminobenzoephenones | |
| GEP20063869B (en) | Novel cyclohexyl sulphones | |
| HK1075654A1 (en) | Hyperforin derivatives, the use thereof and formulations containing them | |
| SE0001916D0 (sv) | Novel formulation | |
| NO995838L (no) | Nye heteroetynylenforbindelser og farmasoeytiske og kosmetiske preparater inneholdende de samme | |
| ATE252383T1 (de) | Verwendung von 2-methyl-thiazolidin-2,4- dicarbonsäure und / oder ihrer physiologisch verträglichen salze zur herstellung eines medikaments zur behandlung von krebserkrankungen | |
| ATE293445T1 (de) | Herstellung reiner stereoisomere von tricyclo- (5.2.1.0(2.6) )-dec-9-yl-xanthogenat sowie deren verwendung als arzneimittel | |
| ATE261732T1 (de) | Pharmazeutische zusammensetzung, umfassend eukalyptus- und orangenöl | |
| ATE241640T1 (de) | Fusidinsäure-derivate | |
| AR030945A1 (es) | Amidas de acido fenilciclohexanocarboxilico sustituido y su uso | |
| ATE334675T1 (de) | Arzneimittel enthaltend substituierte 2,5- diaminomethyl-1h-pyrrole | |
| WO2003066806A3 (en) | Therapeutic use of aziridino compounds |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1497250 Country of ref document: EP |